Two common viruses known to be associated with human cancers are both present - and may even be collaborating with each other - in most male prostate cancers, a new study suggests. The research involved examination of 100 specimens of normal, malignant and benign prostate samples from Australian...
Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, University of Missouri...
A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with minimal radiation exposure...
Prostate cancer patients with advanced tumors that have spread to bone have a poor chance of surviving. Patients with the disease may now live longer with a new line of radioisotope therapy, said researchers at the Society of Nuclear Medicine's 2012 Annual Meeting. The skeletal systemis the...
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the...
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer...
Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study presented to the American Urological Association. LUTS...
Alterations to the "on-off" switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, a Mayo Clinic study has found. These biomarkers - known as DNA methylation profiles - also...
Ryan O'Neal is fighting a new battle. The 70-year-old actor, who was diagnosed with leukemia in 2001, has just revealed that he was recently diagnosed with stage four prostate...
Androgen suppression - the inhibition of testosterone and other male hormones - is a routine therapy for prostate cancer. Unfortunately, it can dramatically reduce the quality of patients' sex lives and, more importantly, lead to cancer recurrence in a more deadly androgen-independent form. A...
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes. If confirmed that heart disease is a risk factor...
Researchers at Queen's University have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer. "This discovery gives us a greater understanding of how aggressive prostate cancer develops...
Advantages for men with metastatic hormone-refractory prostate cancer who are no longer eligible for docetaxel therapy Abiraterone (trade name: Zytiga®) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses...
Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks as some recent studies had suggested according to a new report from Dana-Farber/Brigham and Women's Cancer Center. For men with high-risk prostate tumors, a combination of local treatment and drugs that...
The Prostate Cancer Foundation's Young Investigator awards encourage the most innovative minds in cancer research to investigate prostate cancer. The Foundation awards selected researchers with $225,000 over three years to help support their research on prostate cancer treatment and patients...
New research led by the University of California, San Francisco (UCSF), offers further evidence of a link between aggressive prostate cancer and meat consumption, and suggests it is driven largely by consumption of grilled or barbecued red meat, especially when it is well-done. The...
A recent report in Cancer Discovery, a journal of the American Association for Cancer Research, suggests that a new treatment may be on the horizon for neuroendocrine prostate cancers, the most lethal subtype of this disease. Mark Rubin, M.D., professor of pathology and laboratory medicine at...
Apparently, birth control might be causing prostate cancer in men. How might birth control, something typically ingested by women, end up causing prostate cancer in men? According to a new study, it's likely that estrogen is ending up in our water supply, courtesy of birth control, and by way of...
Prostate cancers are hungry, growing cells. Now we know how to cut off their food supply thanks to research to be published later this month in Cancer Research work funded by Movember and the Prostate Cancer Foundation of Australia. Researchers at the Centenary Institute in Sydney have...
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health...